These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3883672)

  • 21. [The management of Hodgkin's disease with chemotherapy or combined modality treatment].
    Tsushita K; Utsumi M; Shimoyama M
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2202-9. PubMed ID: 9881076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pediatric Hodgkin's disease.
    Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
    J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lymphomas. Treatment of malignant lymphomas. Current observations and future prospects].
    Klastersky J
    Rev Med Brux; 1982 Apr; 3(4):223-34. PubMed ID: 6178138
    [No Abstract]   [Full Text] [Related]  

  • 24. [3-Year results of the combined (polychemo- and radio-) therapy of stage IIIB-IV lymphogranulomatosis].
    Baĭsogolov GD; Isaev IG
    Med Radiol (Mosk); 1982 Nov; 27(11):39-40. PubMed ID: 6897438
    [No Abstract]   [Full Text] [Related]  

  • 25. [Status of the heart during a combined method of treating patients with stage I to II lymphogranulomatosis].
    Astapov BM; Shakhtarina SV
    Med Radiol (Mosk); 1988 Jul; 33(7):36-40. PubMed ID: 3398753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hodgkin's disease in childhood: therapy results in Argentina.
    Sackmann-Muriel F; Bonesana AC; Pavlovsky S; Papendieck C; Morgenfeld M; Penchansky L; Schwartz L; Kvicala R; Sica M; Ojeda F
    Am J Pediatr Hematol Oncol; 1981; 3(3):247-54. PubMed ID: 7025683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Changes in the lungs in patients with lymphogranulomatosis, Stages I-II, following combination therapy].
    Baĭsogolov GD; Afanasova NV; Khmelevskaia ZI; Shakhtarina SV
    Med Radiol (Mosk); 1985 Mar; 30(3):18-22. PubMed ID: 3838568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
    Muwakkit S; Geara F; Nabbout B; Farah RA; Shabb NS; Hajjar T; Khogali M
    Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of Hodgkin's disease including the staging laparotomy].
    Yosida T; Nakanisi J; Kobayasi S; Ohtake S; Ito K; Nakamura S; Hattori K; Saito Y; Tanimoto K
    Rinsho Ketsueki; 1984 Jun; 25(6):827-34. PubMed ID: 6548266
    [No Abstract]   [Full Text] [Related]  

  • 31. The cure of Hodgkin's disease with drugs.
    DeVita VT; Hubbard SM; Moxley JH
    Adv Intern Med; 1983; 28():277-302. PubMed ID: 6188346
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of 5-year results of the scheduled treatment of lymphogranulomatosis in children].
    Makhomova LA; Poliakov VE; Goldobenko GV; Susuleva NA; Tsygankin VI
    Pediatriia; 1989; (2):42-6. PubMed ID: 2657631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease].
    Wang WH; Li YX; Song YW; Jin J; Liu YP; Wang SL; Zhou LQ; Liu XF; Yu ZH; Han JZ
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):218-21. PubMed ID: 16875611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
    Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twenty-year disease and treatment-associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation.
    Sénécal D; Jais JP; Desablens B; Berthou C; Casassus P; Moles MP; Delwail V; Gastinne T; Colonna P; Andrieu JM
    Cancer; 2008 Feb; 112(4):846-55. PubMed ID: 18072259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Secondary malignant tumors following treatment of Hodgkin's disease].
    Shishkin IP
    Med Radiol (Mosk); 1984 Aug; 29(8):24-8. PubMed ID: 6590941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Combination chemotherapy of Hodgkin's disease with vincristine, cyclophosphamide, procarbazine, and prednisolone].
    Aiba K; Ogawa M; Inagaki J; Horikoshi N; Ezaki K; Inoue K; Dohmyo M; Nagata T; Miyamoto H; Kobayashi T; Kuraishi Y
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1928-32. PubMed ID: 6897857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.
    Hudson MM; Krasin M; Link MP; Donaldson SS; Billups C; Merchant TE; Kun L; Billet AL; Kaste S; Tarbell NJ; Howard S; Friedmann AM; Hurwitz CA; Young JA; Marcus KC; Rai S; Cowan T; Weinstein HJ
    J Clin Oncol; 2004 Nov; 22(22):4541-50. PubMed ID: 15542805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recurrences in lymphogranulomatosis].
    Kovalenko NS; Fokina NT
    Ter Arkh; 1983; 55(8):43-8. PubMed ID: 6688890
    [No Abstract]   [Full Text] [Related]  

  • 40. [Current therapy concepts in early and intermediate stages of Hodgkin diseases in adults].
    Glanzmann C; Stahel R
    Praxis (Bern 1994); 1995 Oct; 84(41):1140-7. PubMed ID: 7481323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.